ArticleThoracic cancer2022

Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Mengqing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.